{"id":346689,"date":"2026-11-13T16:17:09","date_gmt":"2026-11-13T10:47:09","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/natco-pharma-q2-results-fy27-pat-203-crore\/"},"modified":"2026-11-13T16:17:09","modified_gmt":"2026-11-13T10:47:09","slug":"natco-pharma-q2-results-fy27-pat-203-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/natco-pharma-q2-results-fy27-pat-203-crore\/","title":{"rendered":"Natco Pharma Q2 Results FY27: PAT Falls 60.88%, Revenue Rs 967.30 Cr, PAT Rs 202.60 Cr"},"content":{"rendered":"
\n

Quick Answer<\/strong><\/p>\n

Natco Pharma Q2 Results FY27 were declared on 13 November 2026, with revenue that fell 29.03% YoY to Rs 967.30 Cr from Rs 1,363.00 Cr, while net profit fell 60.88% YoY to Rs 202.60 Cr from Rs 517.90 Cr. These quarterly results on a consolidated basis show revenue with no YoY growth, as it fell 29.03%, and the YoY growth picture is the first thing to read in the Financial Highlights table below.<\/p>\n<\/div>\n

Natco Pharma Ltd<\/a> (NATCOPHARM) Q2 Results FY27 announced on 13 November 2026, covering the company’s financial performance for the July to September 2026 quarter. The Consolidated results show revenue of Rs 967.30 Cr and PAT of Rs 202.60 Cr in Natco Pharma Q2 Results FY27, and the results date of 13 November 2026 sets the reference point for every comparison in this article.<\/p>\n

This Univest results analysis of Natco Pharma Q2 Results covers the financial highlights, business drivers, outlook and risks, and it opens with the Financial Highlights table that sits below.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n